The University MS Center (UMSC) combines the multidisciplinary expertise of Hasselt University and Noorderhart Pelt in the field of multiple sclerosis (MS). Within this internationally oriented center of expertise, advanced MS research is performed in order to offer the best possible care for people with MS, now and in the future. The participation of people with MS is primary within the UMSC. The center develops strategic research and training programmes, communicates widely about new insights and collaborates with local and international partners.

The Multiple Sclerosis Data Alliance (MSDA) is a global multi-stakeholder collaboration working to accelerate research insights for innovative care and treatments for people with MS, by: -raising awareness about the importance of research using real-world MS data -enabling better discovery and access to real-world MS data -promoting trustworthy and transparent practices in the way real-world MS data is used The MSDA collaborates with patient communities and organizations to promote the value of research and the importance of MS data.

This European research infrastructure for imaging technologies in the biological and biomedical sciences gives researchers access to a wide range of state-of-the-art technologies for biological and biomedical imaging. In addition, EuBI provides image data support and training for users and providers of this infrastructure.

"The European Graduate School of Neuroscience" is an international research and training network of seven universities in Belgium, Germany, France, the Netherlands and Luxembourg. The aim of the partners is to share expertise, knowledge and infrastructure in order to provide an unique opportunity for master's and PhD students have a unique opportunity to develop their research competences and thus also stimulate mobility. In addition, the aim is to carry out joint doctorates between the partner universities and to accredit a joint master's program in the field of neuroscience.

The Limburg Clinical Research Centre (LCRC) is a unique collaboration between Hasselt University, Jessa Hospital and the Ziekenhuis Oost-Limburg (ZOL). Researchers want to improve the healthcare, by combining both academic research and clinical practice. Through patient-oriented, medical-scientific research, they work towards finding innovative solutions to needs in daily clinical practice. LCRC focuses on the development of better prevention strategies, faster detection methods and treatments in the following medical fields: cardiology, oncology, gynaecology/fertility, infectious diseases, anaesthesia/neurology and orthopedics. In addition, LCRc invests in several service and technology platforms that optimally support the researchers: Limburg University Biobank (UBiLim), Mobile Health Unit (MHU) & Data Science, Good Clinical Practice (GCP) Platform and RELAB, rehabilitation and assistive technology.

BioVille opened its doors in 2010 as a breeding ground for start-up and growing companies active in life sciences. The aim was to help start-up and growing health & care companies by offering them flexible spaces and tailor-made support services. Moreover, BioVille fitted in with Limburg's ambition to make life sciences one of the spearhead sectors in the region. When BioVille was already fully booked in 2012, it was decided to expand with a new building of at least 1,500 m². The DigiHub was also built in 2020, with the focus on companies active in digital health. The third phase of the new building will be completed in 2022 and the office facilities will be expanded further. More than 30 companies and more than 150 colleagues are currently housed at BioVille. The main focus is on health & care, in particular BioTech, MedTech and Digital Health. The shareholders behind this initiative are the Limburg Investment Company LRM, Hasselt University and POM Limburg.

Flanders Vaccine is a non-profit, strategy-driven platform for academic, industrial and public stakeholders with relevant expertise in human and animal immunotherapeutics and vaccines. Flanders Vaccine brings together universities, public and private hospitals, research centres, SMEs, pharma, competence providers, patient organisations, and government bodies to develop novel immunological health solutions and the vaccines of the future.

Euregional projects